Thursday, March 31, 2016

Veracyte Gets $45M In Financing

South San Francisco-based molecular diagnostics developer Veracyte said earlier this week that it has raised $45M in financing, from Visium Healthcare Partners LP. Publicly held Veracyte said the financing comes in a com bination of a term loan agreement and securities purchase option. Veracyte said it will initially received $25M from Visium, of which $5M will go towards paying off an existing loan with Silicon Valley Bank.